AOD-9604
Animal / preclinicalAlso known as: hGH fragment 176-191
Community-reported ranges are anecdotal and not clinically validated. Evidence grade shown reflects the strength of available human data. Not a prescription. Legal status varies by country and changes over time; verify locally.
Overview
The fat-loss fragment of human growth hormone, designed to trigger lipolysis without GH's growth and blood-sugar effects. It went through real human trials — a rarity in this category — which found it well tolerated but without meaningful weight loss, so the honest picture here is mixed.
Mechanism
A GH C-terminal fragment that stimulates lipolysis in preclinical models without GH's growth effects; that separation held up for safety in humans more than for efficacy.
Evidence
Human obesity trials showed good tolerability but were largely negative for weight loss — worth knowing before ranking it in a fat-loss stack.
Community-reported information
Community reports vary. Anecdotal and unvalidated; general information only.
General information only, not tailored to you and not a recommendation. Some regions withhold this entirely.
Half-life
Short.
Storage
Lyophilised: refrigerate. Reconstituted: refrigerate.
Commonly reported side effects
- Not well characterised
- Injection-site reactions reported anecdotally
Legal status by region
- USNot FDA-approved; not a lawful supplement ingredient.
Legal status changes over time; verify locally before relying on this.